102 related articles for article (PubMed ID: 8780752)
21. Co-amplification of 8p12 and 11q13 in breast cancers is not the result of a single genomic event.
Paterson AL; Pole JC; Blood KA; Garcia MJ; Cooke SL; Teschendorff AE; Wang Y; Chin SF; Ylstra B; Caldas C; Edwards PA
Genes Chromosomes Cancer; 2007 May; 46(5):427-39. PubMed ID: 17285574
[TBL] [Abstract][Full Text] [Related]
22. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type ("clinging ductal carcinoma in situ"): a simulator of normal mammary epithelium.
Moinfar F; Man YG; Bratthauer GL; Ratschek M; Tavassoli FA
Cancer; 2000 May; 88(9):2072-81. PubMed ID: 10813719
[TBL] [Abstract][Full Text] [Related]
23. Genomic organization of the 8p11-p12 amplicon in three breast cancer cell lines.
Yang ZQ; Albertson D; Ethier SP
Cancer Genet Cytogenet; 2004 Nov; 155(1):57-62. PubMed ID: 15527903
[TBL] [Abstract][Full Text] [Related]
24. Recurrent homogeneously staining regions in 8p1 in breast cancer and lack of amplification of POLB, LHRH, and PLAT genes.
Saint-Ruf C; Gerbault-Seureau M; Viegas-Péquignot E; Zafrani B; Malfoy B; Dutrillaux B
Cancer Genet Cytogenet; 1991 Mar; 52(1):27-35. PubMed ID: 1706959
[TBL] [Abstract][Full Text] [Related]
25. [Perspectives: FISH on cytological samples].
Courtade-Saïdi M
Ann Pathol; 2011 Nov; 31(5 Suppl):S103-4. PubMed ID: 22054440
[No Abstract] [Full Text] [Related]
26. Abnormal chromosome 8 copy number in cytological smears from breast carcinomas detected by means of fluorescence in situ hybridization (FISH).
Bofin AM; Ytterhus B; Fjøsne HE; Hagmar BM
Cytopathology; 2003 Feb; 14(1):5-11. PubMed ID: 12588304
[TBL] [Abstract][Full Text] [Related]
27. Determination of Her-2/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization.
Jimenez RE; Wallis T; Tabasczka P; Visscher DW
Mod Pathol; 2000 Jan; 13(1):37-45. PubMed ID: 10658908
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive profiling of 8p11-12 amplification in breast cancer.
Gelsi-Boyer V; Orsetti B; Cervera N; Finetti P; Sircoulomb F; Rougé C; Lasorsa L; Letessier A; Ginestier C; Monville F; Esteyriès S; Adélaïde J; Esterni B; Henry C; Ethier SP; Bibeau F; Mozziconacci MJ; Charafe-Jauffret E; Jacquemier J; Bertucci F; Birnbaum D; Theillet C; Chaffanet M
Mol Cancer Res; 2005 Dec; 3(12):655-67. PubMed ID: 16380503
[TBL] [Abstract][Full Text] [Related]
29. Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis.
Murphy DS; Hoare SF; Going JJ; Mallon EE; George WD; Kaye SB; Brown R; Black DM; Keith WN
J Natl Cancer Inst; 1995 Nov; 87(22):1694-704. PubMed ID: 7473818
[TBL] [Abstract][Full Text] [Related]
30. Molecular cytogenetic characterization of the 11q13 amplicon in head and neck squamous cell carcinoma.
Jin C; Jin Y; Gisselsson D; Wennerberg J; Wah TS; Strömbäck B; Kwong YL; Mertens F
Cytogenet Genome Res; 2006; 115(2):99-106. PubMed ID: 17065789
[TBL] [Abstract][Full Text] [Related]
31. Correlation of HER2 overexpression with gene amplification and its relation to chromosome 17 aneuploidy: a 5-year experience with invasive ductal and lobular carcinomas.
Nassar A; Khoor A; Radhakrishnan R; Radhakrishnan A; Cohen C
Int J Clin Exp Pathol; 2014; 7(9):6254-61. PubMed ID: 25337277
[TBL] [Abstract][Full Text] [Related]
32. A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification.
Shuster MI; Han L; Le Beau MM; Davis E; Sawicki M; Lese CM; Park NH; Colicelli J; Gollin SM
Genes Chromosomes Cancer; 2000 Jun; 28(2):153-63. PubMed ID: 10825000
[TBL] [Abstract][Full Text] [Related]
33. Relationship between FRA11F and 11q13 gene amplification in oral cancer.
Reshmi SC; Huang X; Schoppy DW; Black RC; Saunders WS; Smith DI; Gollin SM
Genes Chromosomes Cancer; 2007 Feb; 46(2):143-54. PubMed ID: 17099871
[TBL] [Abstract][Full Text] [Related]
34. Aberrations of chromosome 8 in 16 breast cancer cell lines by comparative genomic hybridization, fluorescence in situ hybridization, and spectral karyotyping.
Rummukainen J; Kytölä S; Karhu R; Farnebo F; Larsson C; Isola JJ
Cancer Genet Cytogenet; 2001 Apr; 126(1):1-7. PubMed ID: 11343771
[TBL] [Abstract][Full Text] [Related]
35. Detection of 11q13 amplification as the origin of a homogeneously staining region in small cell lung cancer by chromosome microdissection.
Xu J; Tyan T; Cedrone E; Savaraj N; Wang N
Genes Chromosomes Cancer; 1996 Nov; 17(3):172-8. PubMed ID: 8946196
[TBL] [Abstract][Full Text] [Related]
36. Chromosome translocations in breast cancer with breakpoints at 8p12.
Courtay-Cahen C; Morris JS; Edwards PA
Genomics; 2000 May; 66(1):15-25. PubMed ID: 10843800
[TBL] [Abstract][Full Text] [Related]
37. Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers.
Letessier A; Sircoulomb F; Ginestier C; Cervera N; Monville F; Gelsi-Boyer V; Esterni B; Geneix J; Finetti P; Zemmour C; Viens P; Charafe-Jauffret E; Jacquemier J; Birnbaum D; Chaffanet M
BMC Cancer; 2006 Oct; 6():245. PubMed ID: 17040570
[TBL] [Abstract][Full Text] [Related]
38. The 11q13 amplicon of a mammary carcinoma cell line.
Lafage M; Nguyen C; Szepetowski P; Pébusque MJ; Simonetti J; Courtois G; Gaudray P; deLapeyriere O; Jordan B; Birnbaum D
Genes Chromosomes Cancer; 1990 Sep; 2(3):171-81. PubMed ID: 2078507
[TBL] [Abstract][Full Text] [Related]
39. Frequent amplification of 8q24, 11q, 17q, and 20q-specific genes in pancreatic cancer.
Mahlamäki EH; Bärlund M; Tanner M; Gorunova L; Höglund M; Karhu R; Kallioniemi A
Genes Chromosomes Cancer; 2002 Dec; 35(4):353-8. PubMed ID: 12378529
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of numerical abnormalities of chromosomes 1 and 17 in proliferative epithelial breast lesions using fluorescence in situ hybridization.
Marinho AF; Botelho M; Schmitt FC
Pathol Res Pract; 2000; 196(4):227-33. PubMed ID: 10782466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
